Paul M. Keller

12.5k citations

81 papers · 6.4k indexed · 3 hit papers · h-index 44

Impact in

Virology top 1%
- HIV Research and Treatment
Epidemiology top 0.5%
- Herpesvirus Infections and Treatments
- Cytomegalovirus and herpesvirus research
- Influenza Virus Research Studies

Papers in

Virology 8
- Poxvirus research and outbreaks 5
Epidemiology 36
- Herpesvirus Infections and Treatments 25
- Cytomegalovirus and herpesvirus research 6

Co-authors: James A. Fyfe Gertrude B. Elion P A Furman Ronald W. Ellis Joseph G. Joyce Richard L. Miller Farida S. Sharief Thomas Vanaman
Journals: Journal of Biological Chemistry (9 papers)Virology (8 papers)Journal of Virology (6 papers)Journal of Medicinal Chemistry (4 papers)The Journal of Infectious Diseases (4 papers)
Partner nations: United States Japan United Kingdom

In The Last Decade

Paul M. Keller

81 papers receiving 5.9k citations

Hit Papers

align trajectories log scale

Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate 1979 · 274 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1979 Journal of Virology
1978 Journal of Biological Chemistry
1976 Journal of Biological Chemistry

Peers

Countries citing papers authored by Paul M. Keller

Since Specialization

Citations

This map shows the geographic impact of Paul M. Keller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul M. Keller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul M. Keller more than expected).

Fields of papers citing papers by Paul M. Keller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul M. Keller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul M. Keller. The network helps show where Paul M. Keller may publish in the future.

Co-authors

The 25 scholars most cited alongside Paul M. Keller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul M. Keller Line = papers co-authored together Paul M. Keller links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Immunogenicity and Protective Efficacy of Bacillus anthracis Poly-γ-d-glutamic Acid Capsule Covalently Coupled to a Protein Carrier Using a Novel Triazine-based Conjugation Strategy Journal of Biological Chemistry ·Joseph G. Joyce, James C. Cook, Donald J. Chabot, Robert W. Hepler, Wesley L. Shoop, Qiuwei Xu, Thomas Stambaugh, Miguel Aste-Amézaga, Su Wang, Lani Indrawati, Mark W. Bruner, Arthur M. Friedlander, Paul M. Keller, Michael J. Caulfield	2005	57
2	Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys Vaccine ·Fan Jiang, Xiaoping Liang, Melanie Horton, Helen C. Perry, Michael Citron, Gwen Heidecker, Tong‐Ming Fu, Joseph G. Joyce, Craig T. Przysiecki, Paul M. Keller, Victor M. Garsky, Roxana Ionescu, Yvette Rippeon, Li Shi, Michael Chastain, Jon H. Condra, Mary-Ellen Davies, Jason J. Z. Liao, Emilio A. Emini, John W. Shiver	2004	275
3	Pressure ulcer risk in hip fracture patients Acta Orthopaedica Scandinavica ·Ronald H Houwing, Marja Rozendaal, W. Wouters-Wesseling, Erik Buskens, Paul M. Keller, J. R. E. Haalboom	2004	41
4	Measurement of cell-mediated immunity with a varicella-zoster virus-specific interferon-? ELISPOT assay: Responses in an elderly population receiving a booster immunization Journal of Medical Virology ·Jeffrey G. Smith, Myron J. Levin, Rupert Vessey, Ivan S. F. Chan, Anthony Hayward, Xu Liu, Robin M. Kaufhold, J. Clair, Ira Chalikonda, Christina Y. Chan, Maryann Bernard, William W. Wang, Paul M. Keller, Michael J. Caulfield	2003	39
5	Enhancement of α-Helicity in the HIV-1 Inhibitory Peptide DP178 Leads to an Increased Affinity for Human Monoclonal Antibody 2F5 but Does Not Elicit Neutralizing Responses in Vitro Journal of Biological Chemistry ·Joseph G. Joyce, William M. Hurni, Michael J. Bogusky, Victor M. Garsky, Xiaoping Liang, Michael Citron, Renee Danzeisen, Michael D. Miller, John W. Shiver, Paul M. Keller	2002	96
6	An Enhanced and Scalable Process for the Purification of SIV Gag-Specific MHC Tetramer Protein Expression and Purification ·Karen M. Grimm, Wendy L. Trigona, Gwendolyn J. Heidecker, Joseph G. Joyce, Tong‐Ming Fu, John W. Shiver, Paul M. Keller, James C. Cook	2001	5
7	Fast characterization of intact proteins using a high‐throughput eight‐channel parallel liquid chromatography/mass spectrometry system Rapid Communications in Mass Spectrometry ·Bingbing Feng, Arun H. Patel, Paul M. Keller, J. Randall Slemmon	2001	25
8	Structure-based combinatorial library design: Discovery of non-peptidic inhibitors of caspases 3 and 8 Journal of Computer-Aided Molecular Design ·Martha S. Head, Margret Ryan, Dennis Lee, Yanhong Feng, Cheryl A. Janson, N.O. Concha, Paul M. Keller, Walter E. DeWolf	2001	3
9	Neutralization of Human Papillomavirus (HPV) Pseudovirions: A Novel and Efficient Approach to Detect and Characterize HPV Neutralizing Antibodies Virology ·Mark D. Yeager, Miguel Aste-Amézaga, Darron R. Brown, Melissa M. Martin, Mayur J. Shah, James C. Cook, Neil D. Christensen, Chris Ackerson, Robert S. Lowe, Judy F. Smith, Paul M. Keller, Kathrin U. Jansen	2000	43
10	The L1 Major Capsid Protein of Human Papillomavirus Type 11 Recombinant Virus-like Particles Interacts with Heparin and Cell-surface Glycosaminoglycans on Human Keratinocytes Journal of Biological Chemistry ·Joseph G. Joyce, Jwu‐Sheng Tung, Craig T. Przysiecki, James C. Cook, E. Dale Lehman, Jeffrey A. Sands, Kathrin U. Jansen, Paul M. Keller	1999	328
11	A substrate combinatorial array for caspases Bioorganic & Medicinal Chemistry Letters ·Dennis Lee, Jerry L. Adams, Martín Brandt, Walter E. DeWolf, Paul M. Keller, Mark A. Levy	1999	8
12	Purification of Virus-like Particles of Recombinant Human Papillomavirus Type 11 Major Capsid Protein L1 from Saccharomyces cerevisiae Protein Expression and Purification ·James C. Cook, Joseph G. Joyce, Hugh A. George, Loren D. Schultz, William M. Hurni, Kathrin U. Jansen, Robert W. Hepler, Charlotte C. Yu Ip, Robert S. Lowe, Paul M. Keller, E. Dale Lehman	1999	90
13	TL1, a Novel Tumor Necrosis Factor-like Cytokine, Induces Apoptosis in Endothelial Cells Journal of Biological Chemistry ·Tianli Yue, Jian Ni, Anne M. Romanic, Juan-Li Gu, Paul M. Keller, Chuanlin Wang, Sanjay Kumar, Guoliang Yu, Timothy K. Hart, Xinkang Wang, Zhengui Xia, Walter E. DeWolf, Giora Feuerstein	1999	95
14	Endothelin-Converting Enzyme: Substrate Specificity and Inhibition by Novel Analogs of Phosphoramidon Biochemical and Biophysical Research Communications ·Paul M. Keller, Chao‐Pin Lee, Ashley Fenwick, Steven T. Atkinson, John D. Elliott, Walter E. DeWolf	1996	16
15	Safety and immunogenicity of one vs. two injections of Oka/Merck varicella vaccine in healthy children The Pediatric Infectious Disease Journal ·Angela Ngai, BRENDA O. STAEHLE, Barbara J. Kuter, NANCY M. CYANOVICH, I. Cho, Holly Matthews, Paul M. Keller, Ann M. Arvin, Barbara Watson, C. J. White	1996	54
16	Use of a continous assay of oxygen consumption to evaluate the pharmacology of 5-lipoxygenase inhibitors Prostaglandins Leukotrienes and Essential Fatty Acids ·John Breton, Paul M. Keller, Marie Chabot‐Fletcher, Leonard M. Hillegass, Walter E. DeWolf, D.E. Griswold	1993	9
17	Characterization of recombinant antistasin secreted by Saccharomyces cerevisiae Protein Expression and Purification ·Craig T. Przysiecki, Joseph G. Joyce, Paul M. Keller, Henry Z. Markus, C. E. Carty, Arpi Hagopian, Mohinder K. Sardana, Christopher T. Dunwiddie, Ronald W. Ellis, William J. Miller, E. Dale Lehman	1992	13
18	Cell-Mediated Immune Responses after Immunization of Healthy Seronegative Children with Varicella Vaccine: Kinetics and Specificity The Journal of Infectious Diseases ·Barbara Watson, Paul M. Keller, Ronald W. Ellis, Stuart E. Starr	1990	51
19	3-Deazaadenosine 5′-triphosphate: A novel metabolite of 3-deazaadenosine in mouse leukocytes Biochemical Pharmacology ·Karen Prus, Gerald Wolberg, Paul M. Keller, James A. Fyfe, Carolyn R. Stopford, Thomas P. Zimmerman	1989	12
20	Successful infection of the common marmoset (Callithrix jacchus) with human varicella-zoster virus Journal of Virology ·P. J. Provost, Paul M. Keller, F. S. Banker, B J Keech, Hilton J. Klein, Robert S. Lowe, D. Holmes Morton, A H Phelps, W. J. McAleer, Ronald W. Ellis	1987	20

About Paul M. Keller

Paul M. Keller is a scholar working on Virology, Epidemiology, Immunology, Microbiology and Animal Science and Zoology, having authored 81 papers that have together received 6.4k indexed citations. Recurring topics across this work include Herpesvirus Infections and Treatments (25 papers), Virus-based gene therapy research (13 papers), Toxin Mechanisms and Immunotoxins (9 papers), Animal Virus Infections Studies (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Cytomegalovirus and herpesvirus research (6 papers), Cell death mechanisms and regulation (5 papers) and Poxvirus research and outbreaks (5 papers). The work is most often cited by research in Virology (766 citations), Epidemiology (3.0k citations), Immunology (1.2k citations), Parasitology (300 citations) and Infectious Diseases (774 citations). Paul M. Keller has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include James A. Fyfe, Gertrude B. Elion, P A Furman, Ronald W. Ellis, Joseph G. Joyce, Richard L. Miller, Farida S. Sharief, Thomas Vanaman, D. Martin Watterson and M H St Clair. Their work appears in journals such as Journal of Biological Chemistry, Virology, Journal of Virology, Journal of Medicinal Chemistry and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact